HPC
TMO icon

HM Payson & Co’s Thermo Fisher Scientific TMO Stock Holding History

HM Payson & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.1M Sell
163,790
-20,885
-11% -$10M 1.09% 26
2026
Q1 		$90.8M Sell
184,675
-28,086
-13% -$15.2M 1.31% 23
2025
Q4 		$123M Buy
212,761
+1,798
+0.9% +$1.02M 1.74% 15
2025
Q3 		$102M Buy
210,963
+4,989
+2% +$2.32M 1.47% 22
2025
Q2 		$83.5M Buy
205,974
+30,268
+17% +$12.7M 1.32% 23
2025
Q1 		$87.4M Buy
175,706
+8,904
+5% +$4.82M 1.53% 21
2024
Q4 		$86.8M Buy
166,802
+12,371
+8% +$6.8M 1.47% 20
2024
Q3 		$95.5M Sell
154,431
-2,455
-2% -$1.45M 1.64% 15
2024
Q2 		$86.8M Buy
156,886
+10,644
+7% +$6.1M 1.58% 18
2024
Q1 		$85M Buy
146,242
+1,478
+1% +$829K 1.58% 17
2023
Q4 		$76.8M Sell
144,764
-1,113
-0.8% -$539K 1.59% 18
2023
Q3 		$73.8M Buy
145,877
+1,012
+0.7% +$539K 1.73% 17
2023
Q2 		$75.6M Buy
144,865
+2,513
+2% +$1.36M 1.7% 15
2023
Q1 		$82M Sell
142,352
-452
-0.3% -$255K 1.97% 13
2022
Q4 		$78.6M Buy
142,804
+4,183
+3% +$2.22M 1.96% 16
2022
Q3 		$70.3M Sell
138,621
-5,127
-4% -$2.87M 1.93% 14
2022
Q2 		$78.1M Buy
143,748
+1,370
+1% +$754K 2% 10
2022
Q1 		$84.1M Buy
142,378
+988
+0.7% +$568K 1.91% 11
2021
Q4 		$94.3M Buy
141,390
+3,608
+3% +$2.25M 2.05% 9
2021
Q3 		$78.7M Buy
137,782
+2,609
+2% +$1.43M 1.92% 11
2021
Q2 		$68.2M Buy
135,173
+8,694
+7% +$4.1M 1.66% 15
2021
Q1 		$57.7M Buy
126,479
+7,991
+7% +$3.81M 1.54% 19
2020
Q4 		$55.2M Buy
118,488
+622
+0.5% +$292K 1.53% 17
2020
Q3 		$52M Buy
117,866
+8,394
+8% +$3.47M 1.6% 17
2020
Q2 		$39.7M Buy
109,472
+5,903
+6% +$1.98M 1.33% 24
2020
Q1 		$29.4M Buy
103,569
+57,853
+127% +$18.2M 1.15% 31
2019
Q4 		$14.9M Buy
45,716
+37,028
+426% +$11.2M 0.48% 59
2019
Q3 		$2.53M Buy
8,688
+993
+13% +$284K 0.09% 131
2019
Q2 		$2.26M Buy
+7,695
New +$2.12M 0.08% 138
2018
Q4 		– Sell
-6,998
Closed -$1.71M – 305
2018
Q3 		$1.71M Sell
6,998
-2,604
-27% -$599K 0.08% 140
2018
Q2 		$1.99M Sell
9,602
-1,071
-10% -$227K 0.09% 136
2018
Q1 		$2.2M Buy
10,673
+153
+1% +$32.1K 0.09% 136
2017
Q4 		$2M Sell
10,520
-1,010
-9% -$193K 0.08% 147
2017
Q3 		$2.18M Buy
11,530
+665
+6% +$120K 0.09% 142
2017
Q2 		$1.9M Buy
10,865
+200
+2% +$33.6K 0.09% 142
2017
Q1 		$1.64M Buy
10,665
+3,800
+55% +$581K 0.07% 152
2016
Q4 		$969K Buy
6,865
+807
+13% +$119K 0.05% 188
2016
Q3 		$964K Hold
6,058
– – 0.05% 185
2016
Q2 		$895K Sell
6,058
-275
-4% -$40.6K 0.04% 184
2016
Q1 		$897K Sell
6,333
-409
-6% -$54.8K 0.05% 180
2015
Q4 		$956K Buy
6,742
+30
+0.4% +$4K 0.05% 182
2015
Q3 		$821K Sell
6,712
-88
-1% -$11.5K 0.04% 182
2015
Q2 		$882K Buy
6,800
+207
+3% +$27K 0.04% 183
2015
Q1 		$886K Hold
6,593
– – 0.04% 181
2014
Q4 		$826K Hold
6,593
– – 0.04% 187
2014
Q3 		$802K Buy
6,593
+8
+0.1% +$973 0.04% 184
2014
Q2 		$777K Hold
6,585
– – 0.04% 185
2014
Q1 		$792K Buy
6,585
+173
+3% +$20.6K 0.04% 177
2013
Q4 		$714K Sell
6,412
-872
-12% -$86.7K 0.04% 186
2013
Q3 		$671K Buy
7,284
+2,272
+45% +$205K 0.04% 192
2013
Q2 		$424K Buy
+5,012
New +$417K 0.03% 218

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

HM Payson & Co's TMO Position: Q2 2026 in Review

HM Payson & Co reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $10M and leaving 163,790 shares worth $82.1M. The position accounts for 1.09% of the portfolio, ranked #26.

HM Payson & Co first reported a position in TMO in Q2 2013 and has held it in 51 quarters since. The position peaked at $123M in Q4 2025. 2,603 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • HM Payson & Co held 163,790 shares of Thermo Fisher Scientific worth $82.1M as of Q2 2026.
  • HM Payson & Co sold 20,885 Thermo Fisher Scientific shares in Q2 2026, an estimated $10M.
  • Thermo Fisher Scientific made up 1.09% of HM Payson & Co's portfolio in Q2 2026, its #26 holding.
  • HM Payson & Co first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 51 quarters since.
  • HM Payson & Co's Thermo Fisher Scientific position peaked at $123M in Q4 2025.
  • 2,603 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.